Cancer Currents Blog Post on Anal Cancer Screening Features DCEG Researchers
, by Elise Tookmanian, Ph.D.
The latest Cancer Currents: An NCI Cancer Research Blog post discusses advances in anal cancer screening in the personal context of anal cancer survivor, Daniel G. Garza. It also focuses on the release of consensus guidelines on anal cancer screening, which focused on screening individuals who have an increased risk of the disease, by an international group of experts representing the International Anal Neoplasia Society.
Our researchers conduct cutting-edge research on anal cancer to quantify anal cancer risk, test the efficacy of the HPV vaccine on anal cancer prevention, and evaluate anal cancer screening tests and biomarkers to inform screening guidelines. Three of our experts were featured in the post: Megan Clarke, Ph.D., M.H.S., investigator in the Clinical Genetics Branch, Sarah S. Jackson, Ph.D., M.P.H., investigator, and Cameron B. Haas, Ph.D., M.P.H., postdoctoral fellow, both in the Infections and Immunoepidemiology Branch.